Status:
COMPLETED
Copeptin in Outcome Prediction of an Acute Psychotic Episode
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Acute Psychotic Episode
Schizophrenia Spectrum and Other Psychotic Disorders
Eligibility:
All Genders
18-55 years
Brief Summary
An acute psychotic episode is a severe psychiatric syndrome which might occur in different psychiatric diagnoses. The outcome prediction of relapse rate of a psychotic episode within a certain time f...
Detailed Description
An acute psychotic episode is a severe psychiatric syndrome characterised by symptoms like delusions, hallucinations, and perceptual disturbances. A psychotic episode might occur in different psychiat...
Eligibility Criteria
Inclusion
- Age 18-55 years
- Acute psychotic episode
- Informed consent as documented by signature
Exclusion
- Limited discernment due to psychiatric disorder to give informed consent
- Acute psychotic Episode due to any organic reason
- Psychotic Episode due to psychotropic substances
- Severe somatic disease (acute myocardial infarction, acute sepsis, acute stroke)
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03235908
Start Date
May 1 2017
End Date
July 31 2020
Last Update
September 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031